Domperidone (10mg) + Simethicone (20mg) + Magaldrate (540mg)
Ranidom Suspension is used in the treatment of acidity, stomach ulcers and bloating.
170 ml in 1 bottle
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Ranidom Suspension is to be taken empty stomach.
Ranidom Suspension is a combination of three medicines: Domperidone, magaldrate and simethicone. Domperidone is a prokinetic which works on the region in the brain that controls vomiting. It also acts on the upper digestive tract to increase the movement of the stomach and intestines, allowing food to move more easily through the stomach. Magaldrate is an inorganic salt that neutralises the excess acid in stomach. Simethicone is an antifoaming medicine which disintegrates gas bubbles and allows easy passage of gas.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Ranidom Suspension may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Ranidom Suspension is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Ranidom Suspension may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Ranidom Suspension should be used with caution in patients with kidney disease. Dose adjustment of Ranidom Suspension may be needed. Please consult your doctor.
Ranidom Suspension should be used with caution in patients with liver disease. Dose adjustment of Ranidom Suspension may be needed. Please consult your doctor.
Use of Ranidom Suspension is not recommended in patients with moderate and severe liver disease.
